Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL
NCT04375683
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Acute Lymphocytic Leukemia, Adult B-Cell
BCR-ABL1 Fusion Protein Expression
Interventions
DRUG:
Flumatinib
Sponsor
Zhongda Hospital